Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$12.04
-2.5%
$11.64
$9.30
$25.36
$558.82M1.12541,462 shs515,700 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$19.29
-5.9%
$21.05
$16.59
$33.14
$483.60M1.06193,338 shs147,576 shs
LENSAR, Inc. stock logo
LNSR
LENSAR
$12.13
-0.6%
$12.79
$3.80
$17.31
$144.77M0.49125,082 shs79,749 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.86
$16.37
$8.15
$19.01
$532.04M2.19327,152 shs220,906 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-0.37%+3.35%+14.71%+0.29%-48.33%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-2.01%-1.49%+8.36%-7.29%-33.02%
LENSAR, Inc. stock logo
LNSR
LENSAR
-1.13%-1.21%-5.21%-5.86%+159.57%
ZimVie Inc. stock logo
ZIMV
ZimVie
-0.16%-0.42%+0.27%+97.90%+15.63%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$12.04
-2.5%
$11.64
$9.30
$25.36
$558.82M1.12541,462 shs515,700 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$19.29
-5.9%
$21.05
$16.59
$33.14
$483.60M1.06193,338 shs147,576 shs
LENSAR, Inc. stock logo
LNSR
LENSAR
$12.13
-0.6%
$12.79
$3.80
$17.31
$144.77M0.49125,082 shs79,749 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.86
$16.37
$8.15
$19.01
$532.04M2.19327,152 shs220,906 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-0.37%+3.35%+14.71%+0.29%-48.33%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-2.01%-1.49%+8.36%-7.29%-33.02%
LENSAR, Inc. stock logo
LNSR
LENSAR
-1.13%-1.21%-5.21%-5.86%+159.57%
ZimVie Inc. stock logo
ZIMV
ZimVie
-0.16%-0.42%+0.27%+97.90%+15.63%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.00
HoldN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.88
Moderate Buy$34.1477.00% Upside
LENSAR, Inc. stock logo
LNSR
LENSAR
2.00
Hold$15.0023.66% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.00
Hold$17.75-5.89% Downside

Current Analyst Ratings Breakdown

Latest LNSR, AVNS, KIDS, and ZIMV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2025
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
8/8/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
JMP Securities
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetMarket Outperform$50.00 ➝ $35.00
8/8/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Outperform
8/6/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$40.00 ➝ $39.00
7/31/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuyNeutral$19.00
7/22/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeUnderweightEqual Weight$9.00 ➝ $19.00
7/14/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
(Data available from 9/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$692.50M0.81$11.47 per share1.05$18.03 per share0.67
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$204.73M2.36N/AN/A$14.64 per share1.32
LENSAR, Inc. stock logo
LNSR
LENSAR
$58.36M2.48N/AN/A$0.42 per share28.88
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M1.18$1.85 per share10.17$13.83 per share1.36
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-$392.10M-$10.07N/A6.96N/A-66.89%6.16%4.57%10/29/2025 (Estimated)
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$37.82M-$1.79N/AN/AN/A-18.92%-6.36%-4.69%11/5/2025 (Estimated)
LENSAR, Inc. stock logo
LNSR
LENSAR
-$31.40M-$4.21N/AN/A-84.49%-737.30%-72.60%11/6/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.70N/AN/A-4.39%6.37%3.34%10/29/2025 (Estimated)

Latest LNSR, AVNS, KIDS, and ZIMV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
LENSAR, Inc. stock logo
LNSR
LENSAR
-$0.0750-$0.15-$0.0750-$0.15$16.55 million$11.36 million
8/5/2025Q2 2025
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$0.18$0.17-$0.01-$1.66$165.50 million$175.00 million
8/5/2025Q2 2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.17-$0.11+$0.06-$0.30$61.40 million$61.08 million
7/30/2025Q2 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.2080$0.26+$0.0520-$0.14$112.60 million$116.66 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
N/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
LENSAR, Inc. stock logo
LNSR
LENSAR
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
0.12
2.64
1.58
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.27
6.66
3.43
LENSAR, Inc. stock logo
LNSR
LENSAR
N/A
1.52
0.88
ZimVie Inc. stock logo
ZIMV
ZimVie
0.56
2.37
1.60

Institutional Ownership

CompanyInstitutional Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
95.17%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%
LENSAR, Inc. stock logo
LNSR
LENSAR
40.15%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.64%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
31.80%
LENSAR, Inc. stock logo
LNSR
LENSAR
66.00%
ZimVie Inc. stock logo
ZIMV
ZimVie
5.41%
CompanyEmployeesShares OutstandingFree FloatOptionable
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2,22746.40 million45.18 millionOptionable
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
20025.07 million17.10 millionOptionable
LENSAR, Inc. stock logo
LNSR
LENSAR
11011.94 million4.06 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77028.21 million26.69 millionOptionable

Recent News About These Companies

Hsbc Holdings PLC Buys New Shares in ZimVie Inc. $ZIMV
Ancora Advisors LLC Raises Position in ZimVie Inc. $ZIMV
Ariel Investments LLC Boosts Stake in ZimVie Inc. $ZIMV
ZimVie (NASDAQ:ZIMV) Sets New 1-Year High - What's Next?
Nuveen LLC Buys New Shares in ZimVie Inc. $ZIMV
ZimVie Reports Second Quarter 2025 Financial Results
Insights into ZimVie's Upcoming Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Avanos Medical stock logo

Avanos Medical NYSE:AVNS

$12.04 -0.31 (-2.49%)
Closing price 03:59 PM Eastern
Extended Trading
$12.02 -0.02 (-0.19%)
As of 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

OrthoPediatrics stock logo

OrthoPediatrics NASDAQ:KIDS

$19.29 -1.20 (-5.86%)
Closing price 04:00 PM Eastern
Extended Trading
$19.30 +0.01 (+0.05%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

LENSAR stock logo

LENSAR NASDAQ:LNSR

$12.13 -0.07 (-0.57%)
Closing price 04:00 PM Eastern
Extended Trading
$12.12 -0.01 (-0.08%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$18.86 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$18.86 0.00 (0.00%)
As of 05:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.